Minotab (Minocycline Hydrochloride)

Minocycline, the active ingredient in Minotab, is a tetracycline antibiotic commonly presented as an oral tablet for systemic use. It is employed to treat bacterial infections such as acne vulgaris, respiratory tract infections, urinary tract infections, and skin and soft‑tissue infections in adolescents and adults.

GNH USA supplies Minotab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics. Our network ensures timely delivery across EU and emerging markets.

Minocycline is a tetracycline antibiotic used to treat bacterial infections in several organ systems.

Acne vulgaris: reduces inflammatory lesions and bacterial colonisation. Respiratory tract infections: eradicates susceptible pathogens causing pneumonia and bronchitis. Urinary tract infections: eliminates common uropathogens and relieves symptoms. Skin and soft tissue infections: treats cellulitis, abscesses and other bacterial skin conditions.

Minocycline may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: upset stomach and feeling of sickness. - Diarrhea: loose stools that may be watery. - Photosensitivity: increased skin sensitivity to sunlight. - Dizziness: light‑headedness or vertigo.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Drug‑induced hepatitis: elevated liver enzymes and jaundice. - Pseudotumor cerebri: increased intracranial pressure causing headache and visual changes. - Anaphylaxis: rapid onset of allergic reaction with airway compromise.

When prescribing Minotab, clinicians should consider several safety precautions to minimize risk. - Pregnancy: Category D – use only if benefits outweigh potential fetal risks. - Renal impairment: dose adjustment may be required; monitor kidney function. - Hepatic disease: monitor liver enzymes and avoid in severe dysfunction. - Concomitant anticoagulants: increased bleeding risk; check INR regularly. - Photosensitivity: advise patients to avoid prolonged sun exposure and use sunscreen. - Store at below 25°C: keep in original packaging, protect from moisture and heat.

Minocycline can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Isotretinoin: combined use may increase intracranial hypertension risk. - Oral contraceptives: reduced effectiveness, consider alternative contraception. - Penicillins: antagonistic effect reducing antibacterial activity.

Moderate Interactions (Monitor Closely): - Antacids or supplements containing calcium, magnesium, iron: chelation may decrease absorption; separate dosing by at least 2 hours. - Warfarin: enhanced anticoagulant effect; monitor INR closely. - Methotrexate: increased toxicity; assess renal function and adjust dose if needed.